These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38372128)

  • 1. A real-world study of quality of life following treatment with xylometazoline hydrochloride in individuals with common cold.
    Hagen M; Clark K; Kalita P; Serra G; Sanchez E; Varbiro G; Albasser MM
    Ther Adv Respir Dis; 2024; 18():17534666241228927. PubMed ID: 38372128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of intranasal xylometazoline, alone or in combination with ipratropium, in patients with common cold.
    Eccles R; Martensson K; Chen SC
    Curr Med Res Opin; 2010 Apr; 26(4):889-99. PubMed ID: 20151787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasal decongestants in monotherapy for the common cold.
    Deckx L; De Sutter AI; Guo L; Mir NA; van Driel ML
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD009612. PubMed ID: 27748955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nasal decongestant effect of xylometazoline in the common cold.
    Eccles R; Eriksson M; Garreffa S; Chen SC
    Am J Rhinol; 2008; 22(5):491-6. PubMed ID: 18655753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of topical combinations of ipratropium and xylometazoline for the treatment of symptoms of runny nose and nasal congestion associated with acute upper respiratory tract infection.
    Eccles R; Pedersen A; Regberg D; Tulento H; Borum P; Stjärne P
    Am J Rhinol; 2007; 21(1):40-5. PubMed ID: 17283559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OTC use of a topical nasal spray solution containing xylometazoline plus ipratropium in patients with common cold.
    Strandell B; Norgren-Holst E; Tran N; Jakobsen HB; Chen S
    Int J Clin Pharmacol Ther; 2009 Dec; 47(12):744-51. PubMed ID: 19954713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Observational study investigating Ectoin
    Werkhäuser N; Bilstein A; Mahlstedt K; Sonnemann U
    Eur Arch Otorhinolaryngol; 2022 Mar; 279(3):1371-1381. PubMed ID: 34089097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of an oral formulation of cetirizine and prolonged-release pseudoephedrine versus xylometazoline nasal spray in nasal congestion.
    Stübner UP; Toth J; Marks B; Berger UE; Burtin B; Horak F
    Arzneimittelforschung; 2001 Nov; 51(11):904-10. PubMed ID: 11765592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of xylometazoline nasal spray on nasal conductance in subjects with coryza.
    Hamilton LH
    J Otolaryngol; 1981 Apr; 10(2):109-16. PubMed ID: 6165826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xylometazoline hydrochloride 0.1 per cent versus physiological saline in nasal surgical aftercare: a randomised, single-blinded, comparative clinical trial.
    Humphreys MR; Grant D; McKean SA; Eng CY; Townend J; Evans AS
    J Laryngol Otol; 2009 Jan; 123(1):85-90. PubMed ID: 18405405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decongestant activity of a new formulation of xylometazoline nasal spray: a double-blind, randomized versus placebo and reference drugs controlled, dose-effect study.
    Castellano F; Mautone G
    Drugs Exp Clin Res; 2002; 28(1):27-35. PubMed ID: 12073765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of intranasal xylometazoline and ipratropium in patients with common cold.
    Graf P; Eccles R; Chen S
    Expert Opin Pharmacother; 2009 Apr; 10(5):889-908. PubMed ID: 19351236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of nasal hyperosmolar xylitol and xylometazoline solutions on quality of life in patients with inferior turbinate hypertrophy secondary to nonallergic rhinitis.
    Cingi C; Birdane L; Ural A; Oghan F; Bal C
    Int Forum Allergy Rhinol; 2014 Jun; 4(6):475-9. PubMed ID: 24574278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal topical local anesthetic and decongestant for flexible nasendoscopy in children: a randomized, double-blind, placebo-controlled trial.
    Chadha NK; Lam GO; Ludemann JP; Kozak FK
    JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1301-5. PubMed ID: 24158493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasal decongestants for the common cold.
    Taverner D; Latte J; Draper M
    Cochrane Database Syst Rev; 2004; (3):CD001953. PubMed ID: 15266459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical, double-blind, placebo-controlled study investigating the combination of acetylsalicylic acid and pseudoephedrine for the symptomatic treatment of nasal congestion associated with common cold.
    Loose I; Winkel M
    Arzneimittelforschung; 2004; 54(9):513-21. PubMed ID: 15500197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-to-onset of cold and flu symptom relief: A randomized, double-blind, placebo-controlled pilot study for a multi-symptom combination product.
    Zhang Y; Mallefet P
    Int J Clin Pharmacol Ther; 2018 Dec; 56(12):604-611. PubMed ID: 30220290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasal decongestants for the common cold.
    Taverner D; Latte J
    Cochrane Database Syst Rev; 2007 Jan; (1):CD001953. PubMed ID: 17253470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Decongestant nasal spray. Results of a rhinomanometric double-blind study].
    Maranta CA; Simmen D
    Schweiz Med Wochenschr; 1996 Nov; 126(44):1875-80. PubMed ID: 8984600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasal decongestants for the common cold.
    Taverner D; Bickford L; Draper M
    Cochrane Database Syst Rev; 2000; (2):CD001953. PubMed ID: 10796673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.